- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2021
- 183 Pages
Global
From €3422EUR$3,600USD£2,875GBP
- Report
- September 2024
- 112 Pages
Spain
From €2675EUR$3,014USD£2,326GBP
- Report
- September 2024
- 118 Pages
Italy
From €2675EUR$3,014USD£2,326GBP
- Report
- September 2024
- 128 Pages
France
From €2675EUR$3,014USD£2,326GBP
- Report
- March 2025
- 50 Pages
Global
From €2519EUR$2,650USD£2,116GBP
- Report
- March 2025
- 50 Pages
Global
From €2519EUR$2,650USD£2,116GBP
- Report
- September 2024
- 25 Pages
Spain
From €995EUR$1,121USD£865GBP
- Report
- September 2024
- 111 Pages
New Zealand
From €2675EUR$3,014USD£2,326GBP
- Report
- September 2024
- 26 Pages
Italy
From €995EUR$1,121USD£865GBP
- Report
- September 2024
- 24 Pages
New Zealand
From €995EUR$1,121USD£865GBP
- Report
- September 2024
- 27 Pages
France
From €995EUR$1,121USD£865GBP
Pseudoephedrine is a common active ingredient in Over the Counter (OTC) drugs used to treat nasal and sinus congestion. It is a sympathomimetic amine, which works by stimulating the alpha and beta receptors in the body to reduce swelling in the nasal passages. Pseudoephedrine is available in a variety of forms, including tablets, capsules, liquids, and nasal sprays. It is also available in combination with other medications, such as antihistamines and decongestants.
The OTC pseudoephedrine market is highly competitive, with many manufacturers offering a variety of products. Many of these products are available in both generic and brand name forms. The availability of generic products has helped to reduce the cost of pseudoephedrine, making it more accessible to consumers.
Some of the major companies in the OTC pseudoephedrine market include Johnson & Johnson, Pfizer, GlaxoSmithKline, Merck, and Novartis. These companies offer a wide range of products, including tablets, capsules, liquids, and nasal sprays. Show Less Read more